Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANX007 in Geographic Atrophy (ARCHER)
NCT04656561Phase 2Completed
- Sponsor
- Annexon Biosciences
- Start
- Feb 2021
- Primary completion
- Mar 2023
- Modality
- Antibody Fragments
- Countries
- 3
01
Overview
A Phase 2 trial of vonaprument in geographic atrophy (GA), sponsored by Annexon Biosciences. Started Feb 2021; status: completed.
02
Drugs
vonaprument
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT04656561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04656561.